GENEVA (Reuters) - The World Health Organization supported a decision by the Philippines Department of Health on Tuesday to suspend vaccinations with Sanofi’s dengue drug Dengvaxia, the WHO said in a statement.
“Like many others in the Philippines, WHO is awaiting the expert analysis of new data and advice about its implications for use of the vaccine. In the meantime, WHO supports the Philippines Department of Health’s (DOH) decision to suspend the ongoing vaccination program until more information is available. This is appropriate in the circumstances,” it said.
Reporting by Tom Miles; Editing by Alison Williams